UBS on Thursday downgraded German science and technology company Merck KGaA (MRK.F) to neutral from a buy rating, while maintaining its price target at 150 euros.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)